Better Choice Company Increases Capital Stock Distribution of Halo as Part of the SRx Health Transaction from an 8% to 17% Dividend
Better Choice Company (NYSE: BTTR) has announced an increase in the capital stock distribution of Halo, Purely for Pets, from 8% to 17% dividend as part of its acquisition of SRx Health Solutions. The transaction, which is expected to close in Q1 2025, remains subject to customary closing conditions, including required shareholder approvals from both companies.
Better Choice Company (NYSE: BTTR) ha annunciato un aumento nella distribuzione del capitale delle azioni di Halo, Purely for Pets, dal 8% al 17% di dividendo come parte dell'acquisizione di SRx Health Solutions. La transazione, che si prevede si chiuderà nel primo trimestre del 2025, è soggetta a condizioni di chiusura consuete, inclusi i necessari approvazioni da parte degli azionisti di entrambe le aziende.
Better Choice Company (NYSE: BTTR) ha anunciado un aumento en la distribución de acciones de Halo, Purely for Pets, del 8% al 17% de dividendo como parte de su adquisición de SRx Health Solutions. La transacción, que se espera cierre en el primer trimestre de 2025, está sujeta a condiciones de cierre habituales, incluyendo las aprobaciones necesarias por parte de los accionistas de ambas empresas.
베터 초이스 컴퍼니 (NYSE: BTTR)는 SRx 헬스 솔루션 인수의 일환으로 Halo, Purely for Pets의 자본금 배당금을 8%에서 17%로 증가시키겠다고 발표했습니다. 이 거래는 2025년 1분기에 완료될 것으로 예상되며, 양사 주주의 승인 등 통상적인 거래 종료 조건에 따라 진행됩니다.
Better Choice Company (NYSE: BTTR) a annoncé une augmentation de la distribution d'actions de Halo, Purely for Pets, de 8 % à 17 % de dividende dans le cadre de son acquisition de SRx Health Solutions. La transaction, qui devrait être finalisée au premier trimestre 2025, reste soumise aux conditions de clôture habituelles, y compris les approbations requises des actionnaires des deux entreprises.
Better Choice Company (NYSE: BTTR) hat eine Erhöhung der Kapitalverteilung von Halo, Purely for Pets, von 8% auf 17% Dividende im Rahmen seiner Übernahme von SRx Health Solutions angekündigt. Die Transaktion, die im ersten Quartal 2025 abgeschlossen werden soll, unterliegt den üblichen Abschlussbedingungen, einschließlich der erforderlichen Aktionärsgenehmigungen beider Unternehmen.
- Increased dividend distribution from 8% to 17% for Halo shareholders
- Strategic expansion through SRx Health Solutions acquisition
- Transaction completion dependent on shareholder approvals
- Closing conditions could delay or prevent deal completion
TAMPA, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that as part of the acquisition of SRx Health Solutions Inc. (‘SRx Health’), a leading provider of innovative healthcare solutions, the capital stock distribution of Halo, Purely for Pets, Inc. has increased from an
About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.
About SRX Health
SRx operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. Distinguishing itself as a National Specialty Pharmacy provider, SRx concentrates on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. This unique focus positions SRx to deliver a more holistic and integrated solution, catering to the requirements of both patients and key healthcare stakeholders. Our all-encompassing end-to-end offerings include wholesale/distribution facilities, patient support programs, infusion clinics, retail pharmacies, co-designed clinical programs, clinical trials, and diagnostic services.
Our strategic growth plan is forward-thinking and revolves around fostering increased collaboration with pharmaceutical manufacturers and prescribers. With a specific emphasis on the expanding market of chronic and rare diseases, we target specialty drugs associated with closed and limited distribution networks. The objective is to broaden their distribution and improve accessibility. Our overarching goal is to elevate our current presence from 34 to 100 specialty pharmacy locations across mid-sized population centers throughout Canada, thereby enhancing the scope of healthcare services and establishing new industry benchmarks. In the subsequent phase of SRx's evolution, we aim to extend our reach beyond the borders of Canada. Leveraging our comprehensive approach, we aspire to simplify healthcare on a global scale. For more information on SRx, please visit https://www.srxhealth.ca.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
Better Choice Company, Inc.
Kent Cunningham, CEO
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
FAQ
What is the new dividend percentage for Halo stock in Better Choice Company's (BTTR) SRx Health acquisition?
When is Better Choice Company (BTTR) expected to close the SRx Health acquisition?
What conditions need to be met for Better Choice Company's (BTTR) SRx Health acquisition to complete?
How much did Better Choice Company (BTTR) increase its Halo dividend distribution?
